BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$2.56 +0.36 (+16.36%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Oncology Therapeutics (BBOT) Preferred Shares (2024)

Updated

BridgeBio Oncology Therapeutics' Preferred Shares came in at $646.72 million for Q4 2024.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Preferred Shares (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BridgeBio Oncology Therapeutics 176.55 Mn -920.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 646.72 Mn
API Access

BridgeBio Oncology Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=BBOT&period=max&api_key=YOUR_API_KEY